TattSeal™ has the benefit of years of clinical research and industry leadership. What started years ago with a doctor researching breast cancer prevention solutions, lead to an accidental discovery that his patented MD Matrix is extremely effective when in comes to pain, inflammation, and chronic conditions. Now, a powerful partnership with Discovery Channel reality TV star and founder of Orange County Choppers (OCC) Paul Teutel has TattSeal poised to revolutionize an entire industry.
TattSeal™’s founder, Chris Hardy stands at the forefront of a global movement trending now: the adoption of natural Aloe vera as a primary ingredient in alternative, natural medicine. Hardy is a global leader in developing innovative health, wellness, cosmetic, and anti-aging products. Their partnership started when a friend asked Paul, Sr. to try a new product on his tattoos. It worked so well that they both fell in love with the idea of launching this incredble new product together, and TattSeal™ was born…
We couldn’t be more excited to partner with Paul Sr. Tattseal™ is positioned to disrupt the Tattoo and ink business because of its unique composition and patented formulation that encourage the body to do what it does naturally – repair itself. With early trials, it has far exceeded our expectations with consumers and artists alike.
Christopher Hardy, CEO HW&B, Enterprises. LLC
I am proud and excited to launch this incredible product. As most people know, I am not easy to please. This product has exceeded anything I have ever used for tattoos. What could be better than more tattoos, less pain, and helping veterans?
Paul Teutel, Sr., Founder & Chairman, Orange County Choppers
Mr. Hardy has teamed with a group of physicians led by Dr. Joseph McWherter, M.D., F.A.C.O.G.; F.A.C.S. to create TattSeal™ and other revolutionary natural products in the science of skin repair. MD Matrix™ is patented (U.S. Patent No. 9,610,258) and the research behind it is a paradigm shift in conventional thinking regarding the treatment and prevention of cancer.